Parkinson's Disease Research: Current Insights and Future Directions

A special issue of NeuroSci (ISSN 2673-4087).

Deadline for manuscript submissions: 25 June 2025 | Viewed by 586

Special Issue Editor


E-Mail Website
Guest Editor
Department of Medical Neurobiology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan
Interests: Parkinson’s Disease; neurological disorders; neuroscience; neurobiology; neuron-glia interaction; neuropharmacology; neurotoxicology

Special Issue Information

Dear Colleagues,

Parkinson’s disease (PD) is a debilitating neurodegenerative disorder with a complex pathophysiology, significantly affecting the motor and non-motor functions of millions globally. Despite extensive research efforts, the precise mechanisms underlying PD remain elusive, and current treatments primarily offer symptomatic relief without addressing disease progression. The need for innovative therapeutic strategies and early diagnostic tools is more pressing than ever.

This Special Issue aims to provide a comprehensive overview of the latest advancements in PD research, emphasizing current insights and exploring future directions for effective diagnosis, treatment, and management. We seek to gather cutting-edge research and expert opinions that can deepen our understanding of PD and pave the way for novel therapeutic approaches.

The main focus of this Special Issue will be the evaluation of molecular pathways as pharmacological targets for treatment strategies that may improve the management of Parkinson’s disease. This Special Issue will provide a platform for all pharmaceutical and translational scientists to research important breakthroughs in drug discovery and new therapeutics in this field.

Potential topics include, but are not limited to, those listed below.

Pathophysiology and Molecular Mechanisms

  • Investigations into the genetic, epigenetic, and biochemical pathways involved in PD.
  • Role of α-synuclein aggregation, mitochondrial dysfunction, neuroinflammation, and oxidative stress.

Biomarkers for Early Detection

  • Identification and validation of biomarkers for early and accurate diagnosis.
  • Neuroimaging techniques, cerebrospinal fluid analysis, and blood-based biomarkers.

Innovative Therapeutic Approaches

  • Advances in pharmacological treatments targeting specific molecular pathways.
  • Non-pharmacological therapies such as deep brain stimulation, gene therapy, and stem cell transplantation.

Neuroprotective Strategies

  • Strategies to slow or halt disease progression.
  • Study of neuroprotective agents, lifestyle interventions (diet, exercise), and their impact on disease course.

Genetics and Personalized Medicine

We are pleased to invite you to contribute original articles, reviews, communications, and other forms of scholarly work. We look forward to your contributions to this Special Issue.

Dr. Ikuko Miyazaki
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. NeuroSci is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Parkinson's disease
  • α-synuclein aggregation
  • mitochondrial dysfunction
  • neuroinflammation
  • oxidative stress
  • neuroimaging

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

14 pages, 1598 KiB  
Article
Harmonization for Parkinson’s Disease Multi-Dataset T1 MRI Morphometry Classification
by Mohammed Saqib and Silvina G. Horovitz
NeuroSci 2024, 5(4), 600-613; https://doi.org/10.3390/neurosci5040042 - 29 Nov 2024
Viewed by 267
Abstract
Classification of disease and healthy volunteer cohorts provides a useful clinical alternative to traditional group statistics due to individualized, personalized predictions. Classifiers for neurodegenerative disease can be trained on structural MRI morphometry, but require large multi-scanner datasets, introducing confounding batch effects. We test [...] Read more.
Classification of disease and healthy volunteer cohorts provides a useful clinical alternative to traditional group statistics due to individualized, personalized predictions. Classifiers for neurodegenerative disease can be trained on structural MRI morphometry, but require large multi-scanner datasets, introducing confounding batch effects. We test ComBat, a common harmonization model, in an example application to classify subjects with Parkinson’s disease from healthy volunteers and identify common pitfalls, including data leakage. We used a multi-dataset cohort of 372 subjects (216 with Parkinson’s disease, 156 healthy volunteers) from 11 identified scanners. We extracted both FreeSurfer and the determinant of Jacobian morphometry to compare single-scanner and multi-scanner classification pipelines. We confirm the presence of batch effects by running single scanner classifiers which could achieve wildly divergent AUCs on scanner-specific datasets (mean:0.651 ± 0.144). Multi-scanner classifiers that considered neurobiological batch effects between sites could easily achieve a test AUC of 0.902, though pipelines that prevented data leakage could only achieve a test AUC of 0.550. We conclude that batch effects remain a major issue for classification problems, such that even impressive single-scanner classifiers are unlikely to generalize to multiple scanners, and that solving for batch effects in a classifier problem must avoid circularity and reporting overly optimistic results. Full article
(This article belongs to the Special Issue Parkinson's Disease Research: Current Insights and Future Directions)
Show Figures

Figure 1

Back to TopTop